Commissioning Policies

Home > Policies and Publications > Commissioning Policies

Commissioning policies (containing information about treatments)

Commissioning policies contain information about treatments, and who can have those treatments paid for by the NHS.  The majority of health care services provided by the NHS are routinely available and free at the point of delivery; this provision is not changing. 

However, some drugs, operations and care may not be routinely funded by the NHS. Normally this is because they:

  • Are not deemed clinically effective or effectiveness has yet to be determined.
  • Are not cost-effective in comparison to all the competing demands on NHS funding.
  • Have a low clinical priority and offer little health gain.
  • Are largely cosmetic in nature.

As an Integrated Care Board (ICB), we have a responsibility to make rational decisions in determining the way in which we allocate resources and to act fairly between patients. In June 2022, we inherited approximately 150 commissioning policies from former Clinical Commissioning Groups (CCGs) which set out their local position for the more common clinical conditions/treatments which are not routinely funded.  This has highlighted a variation across the geographic areas of Humber and North Yorkshire. A clinically and professionally led group is therefore leading the review of all clinical policies with the ultimate aim of reducing variation in approach and to help reduce health inequalities. This work is expected to be completed by 31 March 2025. Until a commissioning policy has been harmonised, the existing policy will remain in operation.  Current policies and those policies under review are set out below.

ICB-wide approved commissioning policies can be found here

Abdominoplasty (including repair of Diastasis Recti) and Apronectomy
IIA Abdominoplasty (including repair of Diastasis Recti) and Apronectomy
Commissioning Policy
Integrated Impact Assessment
Adult Bariatric Surgery Tier 4 and follow-up pathway
IIA Adult Bariatric Surgery Tier 4 and follow-up pathway
Commissioning Policy
Integrated Impact Assessment
Arthroscopic hip surgery
IIA Arthroscopic hip surgery
Commissioning Policy
Integrated Impact Assessment
Arthroscopic shoulder decompression
IIA Arthroscopic shoulder decompression
Commissioning Policy
Integrated Impact Assessment
Botulinum toxin A injections into the bladder wall
IIA Botulinum toxin A injections into the bladder wall
Commissioning Policy
Integrated Impact Assessment
Breast Asymmetry Correction
IIA Breast Asymmetry Correction
Commissioning Policy
Integrated Impact Assessment
Breast Prosthesis Removal with or without Replacement
IIA Breast Prosthesis Removal with or without Replacement
Commissioning Policy
Integrated Impact Assessment
Carpal Tunnel Syndrome Release
IIA Carpal Tunnel Syndrome Release
Commissioning Policy
Integrated Impact Assessment
Cleft (split) earlobe surgery 
IIA Cleft (split) earlobe surgery 
Commissioning Policy
Integrated Impact Assessment
Complementary alternative therapies
IIA Complementary alternative therapies
Commissioning Policy
Integrated Impact Assessment
Corrective Surgery, Lens Implants and Laser Treatment for Refractive error (short or long sightedness, astigmatism) 
IIA Corrective Surgery, Lens Implants and Laser Treatment for Refractive error (short or long sightedness, astigmatism) 
Commissioning Policy
Integrated Impact Assessment
Continuous Glucose Monitoring
IIA Continuous Glucose Monitoring
Commissioning Policy
Integrated Impact Assessment
Dermal Fillers
IIA Dermal Fillers
Commissioning Policy
Integrated Impact Assessment
Dilation and Curettage (D&C) for diagnosis or treatment for heavy menstrual bleeding
IIA Dilation and Curettage (D&C) for diagnosis or treatment for heavy menstrual bleeding
Commissioning Policy
Integrated Impact Assessment
Elective Caesarean Section (non-clinical reasons)
IIA Elective Caesarean Section (non-clinical reasons)
Commissioning Policy
Integrated Impact Assessment
Epididymal Cyst Surgery
IIA Epididymal Cyst Surgery
Commissioning Policy
Integrated Impact Assessment
Extra Corporeal Shockwave Therapy (ESWT), Ankle, Elbow, Heel, Hip, Shoulder
IIA Extra Corporeal Shockwave Therapy (ESWT), Ankle, Elbow, Heel, Hip, Shoulder
Commissioning Policy
Integrated Impact Assessment
Eyelid Surgery (Blepharoplasty)
IIA Eyelid Surgery (Blepharoplasty)
Commissioning Policy
Integrated Impact Assessment
Face, Neck and Brow lifts (Rhytidectomy)
IIA Face, Neck and Brow lifts (Rhytidectomy)
Commissioning Policy
Integrated Impact Assessment
Ganglion Excision
IIA Ganglion Excision
Commissioning Policy
Integrated Impact Assessment
Hair Removal by Intense pulsed light (IPL), laser or electrolysis for Hirsutism
IIA Hair Removal by Intense pulsed light (IPL), laser or electrolysis for Hirsutism
Commissioning Policy
Integrated Impact Assessment
Hair Replacement Technologies
IIA Hair Replacement Technologies
Commissioning Policy
Integrated Impact Assessment
Health Optimisation
IIA Health Optimisation
Commissioning Policy
Integrated Impact Assessment
Hyperhidrosis treatment with Botulinum Toxin
IIA Hyperhidrosis treatment with Botulinum Toxin
Commissioning Policy
Integrated Impact Assessment
Ilizarov Technique Taylor Spatial Frame (TSF) (Frame surgery)
IIA Ilizarov Technique Taylor Spatial Frame (TSF) (Frame surgery)
Commissioning Policy
Integrated Impact Assessment
Incision and Curettage of Chalazion
IIA Incision and Curettage of Chalazion
Commissioning Policy
Integrated Impact Assessment
Infusion therapy – Chronic non-cancer pain
IIA Infusion therapy – Chronic non-cancer pain
Commissioning Policy
Integrated Impact Assessment
Liposuction
IIA Liposuction
Commissioning Policy
Integrated Impact Assessment
Male Gynaecomastia Reduction Surgery
IIA Male Gynaecomastia Reduction Surgery
Commissioning Policy
Integrated Impact Assessment
Open, Wide Bore and Upright Magnetic Resonance Imaging (MRI)
IIA Open, Wide Bore and Upright Magnetic Resonance Imaging (MRI)
Commissioning Policy
Integrated Impact Assessment
Photodynamic Therapy (PDT) – for Central Serous Retinopathy
IIA Photodynamic Therapy (PDT) – for Central Serous Retinopathy
Commissioning Policy
Integrated Impact Assessment
Pinnaplasty (Otoplasty)
IIA Pinnaplasty (Otoplasty)
Commissioning Policy
Integrated Impact Assessment
Referral to Specialist Chronic Fatigue Services
IIA Referral to Specialist Chronic Fatigue Services
Commissioning Policy
Integrated Impact Assessment
Resperate© (Intercure Ltd)
IIA Resperate© (Intercure Ltd)
Commissioning Policy
Integrated Impact Assessment
Reversal of Sterilisation
IIA Reversal of Sterilisation
Commissioning Policy
Integrated Impact Assessment
Sacral nerve stimulation (neuromodulation) for Idiopathic chronic urinary retention in Men and Women
IIA Sacral nerve stimulation (neuromodulation) for Idiopathic chronic urinary retention in Men and Women
Commissioning Policy
Integrated Impact Assessment
Sacral Nerve Stimulation (SNS) – Faecal Retention
IIA Sacral Nerve Stimulation (SNS) – Faecal Retention
Commissioning Policy
Integrated Impact Assessment
Snoring Surgery (in the absence of obstructive sleep apnoea) 
IIA Snoring Surgery (in the absence of obstructive sleep apnoea) 
Commissioning Policy
Integrated Impact Assessment
Spinal Injections & Facet joint injections of Local Anaesthetic and Steroid (Sciatica)
IIA Spinal Injections & Facet joint injections of Local Anaesthetic and Steroid (Sciatica)
Commissioning Policy
Integrated Impact Assessment
Tattoo Removal
IIA Tattoo Removal
Commissioning Policy
Integrated Impact Assessment
Thigh and buttock lift
IIA Thigh and buttock lift
Commissioning Policy
Integrated Impact Assessment
Tier 3 Weight Management Services
IIA Tier 3 Weight Management Services
Commissioning Policy
Integrated Impact Assessment
Tonsillectomy for Recurrent Tonsillitis
IIA Tonsillectomy for Recurrent Tonsillitis
Commissioning Policy
Integrated Impact Assessment
Trigger finger release surgery
IIA Trigger finger release surgery
Commissioning Policy
Integrated Impact Assessment
Varicose vein interventions
IIA Varicose vein interventions
Commissioning Policy
Integrated Impact Assessment
Vasectomy
IIA Vasectomy
Commissioning Policy
Integrated Impact Assessment
Wireless or Implantable Functional Electrical Stimulation (FES)
IIA Wireless or Implantable Functional Electrical Stimulation (FES)
Commissioning Policy
Integrated Impact Assessment

ICB-wide approved commissioning policies can be found here
Please note: The lists of commissioning policy statements above are not exhaustive of all interventions not routinely commissioned. For any medical procedure or treatment that is not routinely commissioned and where there is not a specific policy statement, a request via the Individual Funding Request (IFR) process must still be made. Click here to view the IFR policy.

ICB-wide commissioning policies which are not routinely commissioned can be found here

  • Hyaluronic Acid Injections for Musculoskeletal Joint Pain (Synvisc)
  • Penile Prothesis (Implants) Surgery
  • Sativex – Delta-9-Tetrahydrocannabinol and Cannabidiol Oromucosal Spray

Please note: The lists of commissioning policy statements above are not exhaustive of all interventions not routinely commissioned. For any medical procedure or treatment that is not routinely commissioned and where there is not a specific policy statement, a request via the Individual Funding Request (IFR) process must still be made. Click here to view the IFR policy.

Commissioning policies aligned to CCG areas which remain in operation can be found here

Humber aligned (covers all East Riding of Yorkshire, Hull, North East Lincolnshire, North Lincolnshire)

East Riding of Yorkshire Plus Access to Infertility Treatment Policy

Hull Plus Lower urinary tract symptoms in men overview

North East Lincolnshire Plus Goole Neuro Rehab

North Lincolnshire Plus Goole Neuro Rehab

North Yorkshire

Vale of York

Please note: The lists of commissioning policy statements above are not exhaustive of all interventions not routinely commissioned. For any medical procedure or treatment that is not routinely commissioned and where there is not a specific policy statement, a request via the Individual Funding Request (IFR) process must still be made. Click here to view the IFR policy.

Policies which are currently under review

The order in which commissioning policies will be reviewed can be found below.  The policy review process considers any new clinical evidence, national guidance such as NICE, Evidence Based Interventions, or any empirical evidence.  The review will consider variations across the ICB’s geographical area and explore possible options for harmonisation.  In some cases, this may result in a recommendation to increase or reduce access to some services.

Phase 1 – review now complete

Phase 2 – review now complete

Phases 3 – reviews expected to be completed early 2025

  • Anal Fissure Surgery – adults
  • Anal Fissure Surgery – children
  • Botulinum toxin type A for Anal Fissure
  • Botulinum toxin type A for Chronic Migraine
  • Botulinum toxin type A for Spasmodic Dysphonia
  • Bunion surgery (Hallux Valgus)
  • Cataracts Surgery
  • Cataracts Surgery – Second Eye
  • Cataracts Surgery – Shared decision making
  • Circumcision – Male adults/Penile Circumcision
  • Circumcision – Male children
  • Continued Continuous Positive Airway Pressure (CPAP) for Obstructive Sleep Apnoea
  • Cyclone Plus Therapy
  • Endoscopic thoracic sympathectomy-hyperhidrosis
  • Exogen Ultrasound Bone Healing (Exogen Therapy)
  • Grommets for Glue Ear in Children
  • Haemorrhoid surgery
  • Half dose verteporfin photodynamic therapy for the treatment of serious chorioretinopathy – unlicensed indication
  • Hydrocele Correction
  • Hysterectomy for heavy menstrual bleeding
  • Intravitreal Therapies for Eye Disease
  • Irrigation of the external Auditory Canal (for removal of wax)
  • Lycra dynamic splinting for children with neurological impairment
  • Minor foot surgery
  • Oculoplastic eye problems (Oculoplasty)
  • Paediatric – curly toes
  • Resurfacing Procedure; Dermabrasion, Chemical Peels and Laser Treatment
  • Rhinitis (Adult)
  • Rhinoplasty/Septorhinoplasty/Septoplasty
  • Surgical intervention for chronic rhinosinusitis
  • Sleep Study
  • Tendinopathies and musculoskeletal conditions
  • Vasectomy under general anaesthetic
Check+ (For Clinical Use Only)

North of England Commissioning Support (NECS) has developed an online self-service system, Check+, which allows registered users to generate a prior approval ticket (PAT), subject to compliance with the agreed local policy criteria, to attach to the patient record before referral or treatment for Evidence Based Interventions (EBI), related conditions.

Check+ is also a replacement of the existing Individual Funding Request (IFR) system. The new platform allows primary and secondary care users to submit and track the progress of their IFR cases. It will support two-way communication with the IFR team and a referring clinician and provide email notifications to the respective users of any status update.

Click here to access Check+